@article{b8b66798327841469d2bc3c9864b6808,
title = "Outcomes for PTCL: which pathway to success?",
author = "Vose, {Julie M.}",
note = "Funding Information: Conflict-of-interest disclosure: The author has received research/grant support from Astra-Zeneca, Incyte Corp, Kite Pharma, Novartis, Seattle Genetics, Loxo, and Epizyme and has received consultancy fees/honorarium from Abbvie, Epizyme, Vandiam Group, Janssen/Pharmacyclics, Kite Pharma, Astra-Zeneca, Verastem, Miltenyi, Loxo, Allogene, Wugene, Celgene, Roche, Genentech, Karyopharm, and Morphosis.",
year = "2021",
month = may,
day = "13",
doi = "10.1182/blood.2020009850",
language = "English (US)",
volume = "137",
pages = "2570--2571",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "19",
}